Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Molenda
Observed name:
Molenda, Sara
Institutions:
Poznan University of Medical Sciences,
Greater Poland Cancer Center
Observed institutions:
Poznan University of Medical Sciences,
Greater Poland Cancer Center
ORCID:
0000-0003-1352-4084
Observed ORCID:
0000-0003-1352-4084
OpenAlex ID:
A5004698371
Physiological and tumor-associated angiogenesis: Key factors and therapy targeting VEGF/VEGFR pathway
2024
·
Patryk Lorenc
, Agata Sikorska
, et al.
·
Biomedicine & Pharmacotherapy
·
153
KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview
2021
·
Joanna Sobocińska
, Sara Molenda
, et al.
·
International Journal of Molecular Sciences
·
92
PDF
Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
2023
·
Sara Molenda
, Agata Sikorska
, et al.
·
Cancers
·
26
PDF
In vivo study of the immune response to bioengineered spider silk spheres
2022
·
Tomasz Deptuch
, Karolina Penderecka
, et al.
·
Scientific Reports
·
23
PDF
Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
2022
·
Joanna Sobocińska
, Joanna Nowakowska
, et al.
·
Current Oncology
·
14
PDF
ZNF714 Supports Pro-Oncogenic Features in Lung Cancer Cells
2023
·
Urszula Oleksiewicz
, Marta Machnik
, et al.
·
International Journal of Molecular Sciences
·
6
PDF
Developing the Strategy to Use Silk Spheres for Efficient, Targeted Delivery of Oligonucleotide Therapeutics to Cancer Cells
2025
·
Sara Molenda
, Tomasz Deptuch
, et al.
·
International Journal of Nanomedicine
·
3
PDF
ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes
2023
·
Urszula Oleksiewicz
, Marta Machnik
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Macrophage polarization and siRNA-mediated modulation using nanocarriers: molecular, microscopic and functional data
2026
·
Molenda, Sara
·
RepOD
Development of a Doxorubicin Resistance Model in HER2− and HER2+ Breast Cancer to Analyze Potential Therapy Targets and Drug Delivery Methods
2026
·
Sara Molenda
, Katarzyna Gryska
, et al.
·
Cells
PDF
Development of a doxorubicin resistance model in HER2- and HER2+ breast cancer to analyze potential therapy targets and drug delivery methods
2026
·
Molenda, Sara
·
RepOD
Show more works
View as search
Works count:
12
Citation count:
320
H-index:
6
I10-index:
5
Year
Topic
Type